Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 439 followers
Latest posts
Last updated about 16 hours ago
Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Status: Opinion
about 16 hours ago
Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Status: Opinion
Human medicines European public assessment report (EPAR): Ryjunea, Status: Opinion
about 16 hours ago
Human medicines European public assessment report (EPAR): Ryjunea, Status: Opinion
Human medicines European public assessment report (EPAR): Kisunla, donanemab, Status: Opinion
about 16 hours ago
Human medicines European public assessment report (EPAR): Kisunla, donanemab, Status: Opinion
Human medicines European public assessment report (EPAR): Xoanacyl, ferric citrate coordination complex, Status: Opinion
about 16 hours ago
Human medicines European public assessment report (EPAR): Xoanacyl, ferric citrate coordination complex...
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Status: Opinion
5 months ago
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Status: Opinion
about 16 hours ago
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Status: Opinion
29 days ago
Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Status: Opinion
Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Status: Opinion
29 days ago
Human medicines European public assessment report (EPAR): Lynozyfic, linvoseltamab, Status: Opinion
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Status: Opinion
29 days ago
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Status: Opinion
Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion
29 days ago
Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status...
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Status: Opinion
about 2 months ago
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Status: Opinion
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Status: Opinion
about 2 months ago
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Status: Opinion